Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D.

Core Insights - Lantheus Holdings, Inc. has appointed Dr. Phuong Khanh (P.K.) Morrow to its Board of Directors, effective February 1, 2025, enhancing its leadership in radiopharmaceuticals [1][2] - Dr. Morrow brings extensive experience in oncology and drug development, which aligns with Lantheus' strategic initiatives and innovation efforts [2][3] - Following this appointment, the Board will consist of eleven directors, with nine being independent, reflecting a strong governance structure [1] Company Overview - Lantheus is a leading company focused on radiopharmaceuticals, dedicated to enabling clinicians to Find, Fight, and Follow disease for improved patient outcomes [3] - The company has been providing radiopharmaceutical solutions for over 65 years and is headquartered in Massachusetts, with additional offices in Canada and Sweden [3]